MedTrace Logo

Depression and Anxiety Reduction Treatment for Suicide

NCT01941862 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2018-06-19

No results posted yet for this study

Summary

The purpose of this study is to test the effectiveness and usability of multiple computer-based treatments for mood and anxiety relevant risk factors. The target of the treatment is related to cognitive stress, which has been shown to be associated with a variety of negative mental health outcomes such as Post-Traumatic Stress Disorder, suicidal ideation, and substance use disorders.

Conditions

Interventions

BEHAVIORAL

Psychoeducation and Cognitive Bias Modification

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Florida State University

    lead OTHER

Principal Investigators

  • Norman B Schmidt, Ph.D. · Florida State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01941862 on ClinicalTrials.gov